Additional Metadata
Keywords acute leukaemia, FLT3, midostaurin, paediatric, relapsed/refractory
Persistent URL dx.doi.org/10.1111/bjh.15593, hdl.handle.net/1765/116809
Journal British Journal of Haematology
Citation
Zwaan, C.M, Soderhall, S., Brethon, B, Luciani, M., Rizzari, C, Stam, R.W, … Pieters, R. (2018). A phase 1/2, open-label, dose-escalation study of midostaurin in children with relapsed or refractory acute leukaemia. British Journal of Haematology, 185(3), 623–627. doi:10.1111/bjh.15593